Thymidine phosphorylase profiles in nonmalignant and malignant pancreatic tissue. Potential therapeutic role of capecitabine on tumoral and endothelial cells and tumor-infiltrating macrophages

L. Passantino, R. Patruno, P. Valerio, A. Penna, F. Mazzone, A. F. Zito, V. Catalano, A. Pellecchia, E. Jirillo, Girolamo Ranieri

Research output: Contribution to journalArticlepeer-review

Abstract

The drug capecitabine (CAP) is a thymidine Pi-deoxyribosyltransferase (TP) activated oral fluorpyrimidine that generates 5-fluorouracil (5-FU), prefentially, within tumors. Here, in 38 patients with pancreatic cancer we analyzed immunohistochemical TP expression in pancreatic cancer tissue (PCT) and adjacent nonmalignant pancreatic tissue (ANMPT). In addition, a correlation with the main clinical pathological features was made. Furthermore, TP-positive macrophages (MØ) isolated from neoplastic tissue were determined. The mean of TP-positive epithelial cells and endothelial cells in terms of microvessel density was significantly higher in PCT than in ANMPT. Because pancreatic cancer is sensitive to 5-FU, TP-activated oral CAP in tumoral and endothelial cells and tumor infiltrating MØ could increase the concentration of 5-FU at tumor site, thus resulting in an enhanced antitumor activity.

Original languageEnglish
Pages (from-to)95-107
Number of pages13
JournalImmunopharmacology and Immunotoxicology
Volume27
Issue number1
DOIs
Publication statusPublished - 2005

Keywords

  • 5-Fluorouracile
  • Capecitabine
  • Immunohistochemistry
  • Pancreatic cancer
  • Platelet-derived endothelial cell growth factor
  • Thymidine phosphorylase

ASJC Scopus subject areas

  • Immunology
  • Pharmacology
  • Toxicology
  • Health, Toxicology and Mutagenesis

Fingerprint Dive into the research topics of 'Thymidine phosphorylase profiles in nonmalignant and malignant pancreatic tissue. Potential therapeutic role of capecitabine on tumoral and endothelial cells and tumor-infiltrating macrophages'. Together they form a unique fingerprint.

Cite this